Avenique Limited to Consider Bonus Issue for Public Shareholding

Avenique Limited will consider a bonus share issue at its November 5, 2026 board meeting to support compliance with minimum public shareholding requirements. The company has not disclosed a proposed bonus ratio, the current public shareholding level, or the financial effect of the proposed corporate action.

Why is Avenique Limited considering a bonus share issue?

Avenique Limited has scheduled a board meeting for Thursday, November 5, 2026, with the primary agenda of considering a proposal to issue bonus shares. The stated purpose is to meet minimum public shareholding requirements under applicable securities regulations.

The disclosure refers to Rule 19A of the Securities Contracts (Regulation) Rules, 1957, and Regulation 38 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. These provisions require listed companies to maintain the prescribed public shareholding level. The filing does not state Avenique's current public shareholding percentage or identify the specific shareholding shortfall, if any.

What will the Avenique board decide on November 5, 2026?

The Avenique board is due to decide whether to approve the bonus issue proposal on November 5, 2026. The meeting notice also permits consideration of other matters with the chair's approval, but no additional agenda item has been specified in the disclosure.

A bonus issue increases the number of shares held by eligible shareholders without requiring them to pay for the new shares. However, Avenique has not disclosed the proposed bonus ratio, the record date, eligibility conditions, number of shares to be issued, or the expected allotment date. These details would need to be communicated separately if the board approves the proposal.

The company also said its trading window closed on October 30, 2026, and will remain closed until November 7, 2026. The closure applies to designated persons under SEBI's insider trading regulations and is linked to the board meeting considering the bonus issue proposal.

What information has Avenique disclosed so far?

Avenique has disclosed the meeting date, the regulatory objective of the proposal, and the trading-window closure period, while the main economic terms remain unannounced. The company previously reported that its board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, at a meeting held on October 15, 2026.

The available announcement says that the board took the limited review report from statutory auditors on record along with related disclosures. It does not provide revenue, profit, earnings per share, reserves, or other financial-result figures. Therefore, the financial data supplied does not establish the capacity, accounting impact, or capital-structure effect of a possible bonus issue.

What does the disclosure mean for Avenique shareholders and trading?

For shareholders, the announcement is a proposal under board consideration rather than a confirmed bonus issue. The eventual effect on the number of shares held by investors can only be assessed after Avenique discloses the ratio, record date, eligible shareholders, allotment schedule, and revised share capital, if approved.

The supplied information includes a separate statement that Avenique's trading suspension would be revoked effective November 5, 2026 and that shares could resume trading in the XT group on BSE after compliance with SEBI requirements and payment of annual listing fees. Another company-information extract identifies the stock as suspended. The disclosures provided do not explain the status difference, so investors would need to rely on the relevant exchange notice for the applicable trading status.

Avenique also received BSE trading approval for 500,000 equity shares of face value Rs 2 each on October 28, 2026, according to the supplied filings summary. The material does not state how this approval relates to the proposed bonus issue, and it should not be treated as a disclosed bonus-share allotment.

Why do minimum public shareholding rules matter for listed companies?

Minimum public shareholding rules are intended to ensure that a meaningful portion of a listed company's equity is held outside the promoter group. A wider public float can support market participation and allows listed entities to remain aligned with exchange and regulatory requirements.

The method used to address a public-shareholding requirement matters because different corporate actions can affect ownership distribution in different ways. In Avenique's case, the company has only said that a bonus issue is being considered for this purpose. It has not disclosed the post-issue ownership structure or whether public shareholders alone would receive the proposed shares.

Conclusion

Avenique's November 5 board meeting is important because it may determine whether the company adopts a bonus issue as part of its stated effort to meet minimum public shareholding rules. At present, the disclosure confirms the regulatory purpose and meeting schedule but leaves the bonus ratio, record date, allotment timetable, public shareholding level, and financial impact unspecified.

Investors should watch for the board-meeting outcome, including any approved ratio, eligibility terms, record date, revised share-capital details, and clarification on trading status. The trading window is scheduled to reopen on November 7, 2026, while the supplied disclosure also refers to a November 5, 2026 effective date for revocation of trading suspension.